MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
News provided by
Share this article
Share this article
ATMA Was The First Private Sector Service Provider In Canada Conducting Legal Psychedelic-Assisted Therapy For A Palliative Care Patient Under The Approval Of Health Canada's Section 56(1) Exemption
VANCOUVER, BC, April 8, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (
"MINDCURE" or the
"Company") a leader in advanced proprietary technology for psychedelic therapy, is pleased to announce a further strategic equity investment in